The largest database of trusted experimental protocols

9 protocols using sb242084

1

Social Approach in Mice with 5-HT2c Antagonist

Check if the same lab product or an alternative is used in the 5 most similar protocols
20 minutes prior to testing, mice tested for social approach with 5-HT2cR antagonist were given an intraperitoneal injection of SB 242084 (Sigma-Aldrich) diluted to 0.3mg/ml in a 10% (2-hydroxypropyl)-β-cyclodextrin (Sigma-Aldrich) in sterile 25mM citric acid vehicle, or equivalent volume vehicle. For all injections, care was taken to handle animals gently to minimize stress.
+ Open protocol
+ Expand
2

Pharmaceutical Compound Preparation and Administration

Check if the same lab product or an alternative is used in the 5 most similar protocols
WAY163909 [(7b-R,10a-R)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta[b][1,4]diazepino[6,7,1hi]indole] was a gift from Pfizer, Inc. (New York, NY) and dissolved in 0.9% NaCl (vehicle employed for comparison to WAY163909). SB242084 [6-chloro-5-methyl-1-[[2-(2-methylpyrid-3-yloxy)pyrid-5-yl]carbamoyl]indoline dihydrochloride; Sigma Chemical Co., St. Louis, MO, USA] was dissolved in saline containing 10 mmol/L citric acid (Sigma Chemical Co.) and 8% 2-hydroxypropyl-β-cyclodextrin (Trappsol Hydroxpropyl Beta Cyclodextrin, pharmaceutical grade, Cyclodextrin Technologies Development Inc., High Springs, FL, USA) with the final pH of the solution adjusted to 5.6. SB242084, WAY163909, and compound 16 were injected intraperitoneally (ip) at a volume of 1 mL/kg.
+ Open protocol
+ Expand
3

Pharmacological Evaluation of WAY163909

Check if the same lab product or an alternative is used in the 5 most similar protocols
WAY163909 [(7b-R,10a-R)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta[b][1,4] diazepino[6,7,1hi]indole] was a gift from Pfizer, Inc. (New York, NY) and was dissolved in 0.9% NaCl (vehicle employed for comparison to WAY163909). SB242084 [6-chloro-5-methyl-1-[[2-(2-methylpyrid-3-yloxy)pyrid-5-yl]carbamoyl]indoline dihydrochloride; Sigma Chemical Co., St. Louis, MO, USA] was dissolved in saline containing 10 mmol/L citric acid (Sigma Chemical Co.) and 8% 2-hydroxypropyl-β-cyclodextrin (Trappsol hydroxpropyl β cyclodextrin, pharmaceutical grade, Cyclodextrin Technologies Development Inc., High Springs, FL, USA) with the final pH of the solution adjusted to 5.6. SB242084, WAY163909, and compound 12 were injected ip at a volume of 1 mL/kg.
+ Open protocol
+ Expand
4

Pharmacological Modulation of Neuronal Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI), N-Methyl-D-aspartic acid (NMDA), (S)-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) and (2-hydroxyethyl)trimethylammonium chloride carbamate (carbachol) (Sigma-Aldrich, St. Louis, MO) and 2-aminoethyl disulfide dihydrochloride (cystamine) (MP Biomedicals, Solon, OH) were dissolved in saline or water and further diluted before application to cell cultures. SB 242084 (Sigma-Aldrich, St. Louis, MO) was dissolved in ethanol (the final concentration of ethanol exposure to cells was 0.1%). MDL100907 was kindly provided by Sanofi Aventis (Bridgewater, NJ) and dissolved in DMSO (the final concentration of DMSO exposure to cells was 0.01%).
+ Open protocol
+ Expand
5

Pharmacological Manipulation of Serotonin Signaling

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDL 100907, TCB-2, and 25CN-NBOH were purchased from Tocris (Bristol, UK), escitalopram oxalate was purchased from Shodana Labs (Hyderabad, India), pimavanserin was purchased from MedChem Express (Monmouth Junction, NJ, USA), psilocybin was purchased from Chiron Corporation (Emeryville, CA, USA), and SB 242084 was purchased from Sigma-Aldrich (St. Louis, MO, USA). Escitalopram and 25CN-NBOH were dissolved in 0.9% saline. SB 242084 was dissolved in 0.9% saline, 8% cyclodextrin, and 0.48% citric acid. All other drugs were dissolved in 0.9% saline by adding a small volume of 1 M HCl while the solution was heated and stirred. When required, pH was readjusted by adding NaOH. Controls received 0.9% saline. All injections were given subcutaneously with an injection volume of approximately 1 mL. For time points of injections, see Figure 1.
+ Open protocol
+ Expand
6

Pharmacological Modulation of 5-HT Receptors

Check if the same lab product or an alternative is used in the 5 most similar protocols
The injectable anesthetic (+/−)-ketamine and the mixed 5-HT2A/2C receptor agonist (+/−)2,5-Dimethoxy-4-iodoamphetamine (DOI) (Fantegrossi et al., 2008 (link)) were purchased from Sigma-Aldrich (St. Louis, MO) and dissolved in saline. The selective 5-HT2C receptor antagonist, SB-242084 (Kennett et al., 1997 (link)), was purchased from SigmaAldrich (St. Louis, MO) and dissolved in 5% Tween 80, 5% ethanol, and brought to final volume in saline. The selective 5-HT2C receptor agonist, WAY-163909 (Grauer et al., 2009 (link); Marquis et al., 2007 (link)), was provided as a gift from Pfizer (New York, NY) and dissolved in 5% Tween 80 and brought to final volume in saline. All injections were administered intraperitoneally at a volume of 0.01 ml of the drug solution per g body weight of each mouse. All doses are reported in the salt form.
+ Open protocol
+ Expand
7

Serotonin and Dopamine Modulation in Behavioral Testing

Check if the same lab product or an alternative is used in the 5 most similar protocols
SB242084 (Sigma-Aldrich, Atlanta, GA), a 5-HT2C antagonist, was suspended in a vehicle of 0.5% DMSO in saline in the doses of 0.3, 1, and 3 mg/kg (Yoshimoto et al., 2012 (link)). Buspirone (Sigma-Aldrich), a 5-HT1A partial agonist and dopamine D2, D3, D4 antagonist, was dissolved in saline in the doses of 1, 3, and 10 mg/kg (Martin et al., 1992 (link); Rodgers et al., 1997 (link)). Drugs were administered intraperitoneally in a volume of 10 ml/kg 20 min before either testing for two-bottle choice consumption or locomotor activity in the open field.
+ Open protocol
+ Expand
8

Pharmacological Modulation of MDMA Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
MDMA (5 mg/kg), Ketanserin (5 mg/kg), SB242084 (3 mg/kg), Pindolol (0.3 mg/kg) and RU486 (7.5 mg, approximately 30 mg/kg) were purchased from Sigma-Aldrich Co. (Sigma-Aldrich, Israel). All drugs were dissolved in saline (0.9% NaCl) and injected intraperitoneally (i.p.) in a 250 µl volume. Based on the literature [32 (link)–34 (link)] and in considering our preliminary study which didn’t find any significantly differences between saline and MDMA 3 mg/kg in LMA and because of the possibility of neurotoxicity produced by higher dose of 10 mg/kg [35 (link)], the 5 mg/kg dose was chosen for this study. The doses of Ketanserin and SB242084 were selected based on Shinoda’s report [36 (link)]. The dose of Pindolol was selected based on Nash’s report [22 (link)]. The dose of RU486 was selected based on our previous study [37 (link)]. All pre-treatments were administered i.p. 60 min prior to MDMA injection.
+ Open protocol
+ Expand
9

Ferroptosis Inducers and Inhibitors Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Erastin (S7242), RSL3 (S8155), ferrostatin-1 (S7243), liproxstatin-1 (S7699), Z-VAD-FMK (S7023), necrosulfonamide (S8251), staurosporine (S1421), CCT137690 (S2744), olanzapine (S2493), idebenone (S2605), telmisartan (S1738), nisoldipine (S1748), azelnidipine (S3053), and risperidone (S1615) were obtained from Selleck Chemicals (Houston, TX). Cerulein (C9026), L-arginine (A5006), alcohol (PHR1373), 2-mercaptoethanol (M6250), trypsin (T1426), soybean trypsin inhibitor (650357), SB204741 (S0693), and SB242084 (5.06417) were obtained from Sigma-Aldrich (Burlington, MA). Dimethyl sulfoxide (472301; Sigma-Aldrich) was used to prepare the stock solution of most drugs. The final concentration of Dimethyl sulfoxide in the drug working solution in the cells was less than 0.01%. In addition, 0.01% Dimethyl sulfoxide was used as a vehicle control in the corresponding cell culture assays.
The antibodies to PSMD4 (sc-398033) and actin beta (ACTB, sc-8432) were obtained from Santa Cruz Biotechnology (Dallas, TX). The antibodies to GPX4 (ab125066) and SLC7A11 (ab175186) were obtained from Abcam (Cambridge, MA). The antibodies to ferritin heavy chain 1 (3998) and ARNTL (14020) were obtained from Abcam. The antibodies to SLC40A1 (NBP1-21502) and apoptosis inducing factor mitochondria-associated 2 (H00084883-D01P) were obtained from NOVUS (Saint Charles, MO).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!